C. Debieuvre

748 total citations
9 papers, 519 citations indexed

About

C. Debieuvre is a scholar working on Neurology, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, C. Debieuvre has authored 9 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 3 papers in Cognitive Neuroscience and 1 paper in Pharmacology. Recurrent topics in C. Debieuvre's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (6 papers) and Parkinson's Disease and Spinal Disorders (2 papers). C. Debieuvre is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (6 papers) and Parkinson's Disease and Spinal Disorders (2 papers). C. Debieuvre collaborates with scholars based in United States, Germany and Austria. C. Debieuvre's co-authors include Werner Poewe, Olivier Rascol, Paolo Barone, Stefan Albrecht, Daniel Weintraub, Dan Massey, Eduardo Tolosa, Robert A. Hauser, Anthony H.V. Schapira and Yoshikuni Mizuno and has published in prestigious journals such as The Lancet Neurology, Movement Disorders and European Journal of Neurology.

In The Last Decade

C. Debieuvre

9 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Debieuvre United States 6 445 110 98 74 63 9 519
Pavel Ressner Czechia 7 342 0.8× 132 1.2× 53 0.5× 53 0.7× 49 0.8× 25 414
Asunción Ávila Spain 8 230 0.5× 65 0.6× 134 1.4× 75 1.0× 30 0.5× 13 349
W. H. Oertel Germany 12 399 0.9× 232 2.1× 88 0.9× 67 0.9× 63 1.0× 17 576
Herzel Shabtai Israel 6 294 0.7× 86 0.8× 50 0.5× 53 0.7× 48 0.8× 7 379
Lydia López Manzanares Spain 10 416 0.9× 79 0.7× 60 0.6× 53 0.7× 75 1.2× 33 487
Sibel Özekmekçi Türkiye 14 281 0.6× 77 0.7× 76 0.8× 57 0.8× 83 1.3× 27 400
Susan Martorello United States 9 160 0.4× 176 1.6× 95 1.0× 87 1.2× 48 0.8× 11 407
P. De Domenico Italy 6 188 0.4× 106 1.0× 57 0.6× 121 1.6× 25 0.4× 15 367
Mubasher A. Qamar United Kingdom 11 339 0.8× 87 0.8× 69 0.7× 32 0.4× 71 1.1× 24 409
Ariane Park United States 7 252 0.6× 71 0.6× 62 0.6× 82 1.1× 44 0.7× 8 379

Countries citing papers authored by C. Debieuvre

Since Specialization
Citations

This map shows the geographic impact of C. Debieuvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Debieuvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Debieuvre more than expected).

Fields of papers citing papers by C. Debieuvre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Debieuvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Debieuvre. The network helps show where C. Debieuvre may publish in the future.

Co-authorship network of co-authors of C. Debieuvre

This figure shows the co-authorship network connecting the top 25 collaborators of C. Debieuvre. A scholar is included among the top collaborators of C. Debieuvre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Debieuvre. C. Debieuvre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hauser, Robert A., Anthony H.V. Schapira, Paolo Barone, et al.. (2014). Long‐term safety and sustained efficacy of extended‐release pramipexole in early and advanced Parkinson's disease. European Journal of Neurology. 21(5). 736–743. 26 indexed citations
2.
Hauser, Robert A., Mark Forrest Gordon, Yoshikuni Mizuno, et al.. (2014). Minimal Clinically Important Difference in Parkinson’s Disease as Assessed in Pivotal Trials of Pramipexole Extended Release. Parkinson s Disease. 2014. 1–8. 59 indexed citations
3.
Schapira, Anthony H.V., Paolo Barone, Robert A. Hauser, et al.. (2012). Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease. European Journal of Neurology. 20(1). 50–56. 18 indexed citations
4.
Schapira, Anthony H.V., Paolo Barone, Robert A. Hauser, et al.. (2012). Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease. European Journal of Neurology. 20(1). 180–187. 10 indexed citations
5.
Poewe, W., Paolo Barone, R. Hauser, et al.. (2011). 2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE. Parkinsonism & Related Disorders. 18. S131–S132. 1 indexed citations
6.
Rascol, Olivier, Paolo Barone, Robert A. Hauser, et al.. (2010). Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease. Movement Disorders. 25(14). 2326–2332. 30 indexed citations
7.
Barone, Paolo, Werner Poewe, Stefan Albrecht, et al.. (2010). Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. The Lancet Neurology. 9(6). 573–580. 373 indexed citations
8.
Rascol, Olivier, Paolo Barone, R. Hauser, et al.. (2009). P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage. Parkinsonism & Related Disorders. 15. S131–S132. 1 indexed citations
9.
Brecht, Stephan, et al.. (2007). Efficacy of duloxetine in the treatment of unspecific pain associated with depression. European Psychiatry. 22. S225–S225. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pavel Ressner Breakdown of academic impact, for papers by Asunción Ávila Breakdown of academic impact, for papers by W. H. Oertel Breakdown of academic impact, for papers by Herzel Shabtai Breakdown of academic impact, for papers by Lydia López Manzanares Breakdown of academic impact, for papers by Sibel Özekmekçi Breakdown of academic impact, for papers by Susan Martorello Breakdown of academic impact, for papers by P. De Domenico Breakdown of academic impact, for papers by Mubasher A. Qamar Breakdown of academic impact, for papers by Ariane Park
Rankless by CCL
2026